ATROPINE Eye drops Ref.[8250] Active ingredients: Atropine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2016  Publisher: Martindale Pharmaceuticals Ltd, Bampton Road, Harold Hill, Romford, RM3 8UG

Pharmacodynamic properties

Pharmacotherapeutic group: anticholinergic agents
ATC code: S01FA01

Dilation of the pupil normally occurs within half an hour following local application and lasts for seven days or longer. Paralysis of accommodation in one to three hours with recovery in three to seven days.

Pharmacokinetic properties

Atropine is readily absorbed from the gastro-intestinal tract and mucous membranes, it is also absorbed from the eye.

It is incompletely metabolised in the liver and is excreted in the urine as unchanged drug and metabolites.

Preclinical safety data

No additional pre-clinical data of relevance to the prescriber.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.